% alzhub.org topic: plasma-p-tau217
% Source: https://alzhub.org/topic/plasma-p-tau217
% 6 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{rudolph2025-40613474,
  author  = {Rudolph, M. D. and Sutphen, C. L. and Register, T. C. and Lockhart, S. N. and Rundle, M. M. and Hughes, T. M. and Bateman, JR. and Sai, K. K. S. and others},
  title   = {{Evaluation of plasma p-tau217 for detecting amyloid pathology in a heterogeneous community-based cohort}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.70426},
  pmid    = {40613474},
  url     = {https://doi.org/10.1002/alz.70426}
}

@article{ghahremani2025-40406748,
  author  = {Ghahremani, M. and Leon, R. and Smith, E. E. and Ismail, Z.},
  title   = {{Exploring the association between mild behavioral impairment and plasma p-tau217: Implications for early detection of Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  year    = {2025},
  doi     = {10.1002/dad2.70119},
  pmid    = {40406748},
  url     = {https://doi.org/10.1002/dad2.70119}
}

@article{kwon2025-40044785,
  author  = {Kwon, H. S. and Hwang, M. and Koh, S. H. and Choi, S. H. and Lee, J. H. and Kim, H. J. and Park, S. H. and Park, H. H. and others},
  title   = {{Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients}},
  journal = {Scientific reports},
  year    = {2025},
  doi     = {10.1038/s41598-025-90232-8},
  pmid    = {40044785},
  url     = {https://doi.org/10.1038/s41598-025-90232-8}
}

@article{howe2024-38971815,
  author  = {Howe, M. D. and Britton, K. J. and Joyce, H. E. and Menard, W. and Emrani, S. and Kunicki, Z. J. and Faust, M. A. and Dawson, B. C. and others},
  title   = {{Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01521-9},
  pmid    = {38971815},
  url     = {https://doi.org/10.1186/s13195-024-01521-9}
}

@article{molinahenry2024-39044491,
  author  = {Molina-Henry, D. and Langford, O. and Donohue, M. C. and Raman, R. and Aisen, P. and Johnson, K. A. and Rissman, R. A. and Sperling, R.},
  title   = {{Relationship between Plasma P-Tau217 and Amyloid PET in Racial and Ethnic Underrepresented Groups (RE-URG) Compared with Non RE-URG in LEARN and A4}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2024},
  doi     = {10.14283/jpad.2024.124},
  pmid    = {39044491},
  url     = {https://doi.org/10.14283/jpad.2024.124}
}

@article{mundada2023-37740209,
  author  = {Mundada, N. S. and Rojas, J. C. and Vandevrede, L. and Thijssen, E. H. and Iaccarino, L. and Okoye, O. C. and Shankar, R. and Soleimani-Meigooni, D. N. and others},
  title   = {{Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment}},
  journal = {Alzheimer's research \& therapy},
  year    = {2023},
  doi     = {10.1186/s13195-023-01302-w},
  pmid    = {37740209},
  url     = {https://doi.org/10.1186/s13195-023-01302-w}
}